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Abstract: Pyruvate carboxylase (PC) is a biotin-dependent enzyme that 
catalyzes the MgATP- and bicarbonate-dependent carboxylation of pyruvate to 
oxaloacetate, an important anaplerotic reaction in central metabolism. The 
carboxyltransferase (CT) domain of PC catalyzes the transfer of a carboxyl 
group from carboxybiotin to the accepting substrate, pyruvate. It has been 
hypothesized that the reactive enolpyruvate intermediate is stabilized through 
a bidentate interaction with the metal ion in the CT domain active site. 
Whereas bidentate ligands are commonly observed in enzymes catalyzing 
reactions proceeding through an enolpyruvate intermediate, no bidentate 
interaction has yet been observed in the CT domain of PC. Here, we report 
three X-ray crystal structures of the Rhizobium etli PC CT domain with the 
bound inhibitors oxalate, 3-hydroxypyruvate, and 3-bromopyruvate. Oxalate, 
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a stereoelectronic mimic of the enolpyruvate intermediate, does not interact 
directly with the metal ion. Instead, oxalate is buried in a pocket formed by 
several positively charged amino acid residues and the metal ion. 
Furthermore, both 3-hydroxypyruvate and 3-bromopyruvate, analogs of the 
reaction product oxaloacetate, bind in an identical manner to oxalate 
suggesting that the substrate maintains its orientation in the active site 
throughout catalysis. Together, these structures indicate that the substrates, 
products and intermediates in the PC-catalyzed reaction are not oriented in 
the active site as previously assumed. The absence of a bidentate interaction 
with the active site metal appears to be a unique mechanistic feature among 
the small group of biotin-dependent enzymes that act on α-keto acid 
substrates. 
Keywords: biotin-dependent carboxylase, carboxyltransferase, pyruvate 
carboxylase 
Introduction 
Pyruvate carboxylase (PC; EC 6.4.1.1) is a multifunctional, 
biotin-dependent enzyme that catalyzes the bicarbonate- and MgATP-
dependent carboxylation of pyruvate to oxaloacetate, an important 
anaplerotic reaction in central metabolism (reviewed in [1]). Aberrant 
enzyme activities and protein expression levels are associated with 
Type II diabetes, tumor cell proliferation, and bacterial virulence. In all 
eukaryotes and most prokaryotes, PC is a homotetramer, with each 
monomer consisting of four functional domains: the biotin carboxylase 
(BC) domain, the carboxyltransferase (CT) domain, the biotin carboxyl 
carrier protein (BCCP) domain and the central allosteric domain. The 
catalytic reaction requires a covalently tethered biotin cofactor, which 
is initially carboxylated in the BC domain with the hydrolysis of MgATP. 
Following carboxylation, carboxybiotin physically translocates to the CT 
domain where the carboxyl group is transferred to pyruvate to form 
oxaloacetate. 
While the reaction mechanism for the BC domain of PC has been 
extensively investigated, detailed insights into the CT domain reaction 
have only recently emerged. For example, the CT domain of Rhizobium 
etli PC (RePC) utilizes a conserved Thr882 to shuttle a proton from 
pyruvate to the biotin enolate [2], while Arg548, Gln552, and Arg621 
serve to stabilize the enolpyruvate intermediate [3,4], and Asp590 and 
Tyr628 form a substrate-induced biotin binding pocket to 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemical and Biophysical Research Communications, Vol. 441, No. 2 (November 2013): pg. 377-382. DOI. This article is 
© Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not 
grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Elsevier. 
3 
 
accommodate the insertion of carboxybiotin into the active site [5]. 
Recent X-ray crystal structures of PC have shown pyruvate bound in 
the active site [5–7] but, surprisingly, pyruvate does not coordinate 
the active site metal through a bidentate interaction. This unexpected 
pyruvate binding pose raises questions about the role of the metal ion 
in the carboxyltransferase reaction. A structure of the product, 
oxaloacetate, bound in the active site would further clarify the position 
of reactants relative to the active site metal ion. However, attempts at 
determining a structure of PC with bound oxaloacetate have not been 
successful, largely due to the relatively rapid rate of spontaneous 
oxaloacetate decarboxylation [5,6]. 
Here we report three X-ray crystal structures of the CT domain 
from RePC with bound analogs of the reaction intermediate and 
product (Figure 1). The structure with oxalate, a stereoelectronic 
mimic of the enolpyruvate intermediate, suggests that the metal 
center does not directly participate in the reaction mechanism. Taken 
together with the structures of the CT domain with the product 
analogs, 3-hydroxypyruvate and 3-bromopyruvate, these structures 
contribute new details to the mechanistic description of the PC 
catalyzed reaction. 
 
Figure 1 Structures of the reaction substrate (pyruvate), reaction intermediate 
(enolpyruvate), reaction product (oxaloacetate), reaction intermediate analog 
(oxalate), and two reaction product analogs (3-hydroxypyruvate and 3-
bromopyruvate). 
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Materials and Methods 
General 
Oxalate and 3-bromopyruvate were purchased from Alfa Aesar. 
All other materials, including 3-hydroxypyruvate, were purchased from 
Sigma-Aldrich. ΔBCΔBCCP RePC was previously subcloned into a 
modified pET-28a vector for recombinant expression in λ(DE3) 
lysogenized Escherichia coli BL21Star [5]. 
Protein Purification 
ΔBCΔBCCP RePC protein was purified and concentrated as previously 
described [5]. 
Isothermal Titration Calorimetry 
ITC experiments were performed using a Microcal ITC200 (GE 
Life Sciences) with 296 μM ΔBCΔBCCP RePC in 20 mM HEPES buffer 
(pH 7.5) in the ITC cell. This was titrated with 10 mM pyruvate or 3 
mM oxalate in 20 mM HEPES buffer (pH 7.5). The binding isotherm 
was calculated after subtracting a control titration into an ITC cell 
containing 20 mM HEPES buffer (pH 7.5). Binding isotherms were fit to 
a one site binding model. 
Protein Crystallization 
ΔBCΔBCCP RePC co-crystallization with oxalate  
ΔBCΔBCCP RePC was crystallized using the batch crystallization 
method under oil, as previously described [5]. Crystallization 
conditions for the three crystal structures were nearly identical. For the 
ΔBCΔBCCP RePC structure containing oxalate, the protein solution 
consisting of 10 mg/mL ΔBCΔBCCP RePC and 25 mM oxalate was 
mixed at a 1:1 ratio with the precipitant solution comprised of 11.3% 
(w/v) PEG 8000, 99 mM BisTris (pH 6.0), and 346 mM 
tetramethylammonium chloride (TMACl). A seed stock was generated 
using the seed bead kit from Hampton Research (Aliso Viejo, CA). 
Briefly, a single apoprotein ΔBCΔBCCP RePC crystal was pulverized in 
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500 μL of precipitant solution and 0.5 μL of the seed solution was 
added to the crystallization drop immediately following mixing. The 
drop was covered with paraffin oil and diamond shaped crystals 
formed with 2–3 days. After 5–7 days, the crystals were serially 
transferred in 5% (v/v) glycerol increments from a synthetic mother 
liquor solution consisting of 11% (w/v) PEG 8000, 70 mM BisTris (pH 
6.0), 275 mM TMACl, 5% (v/v) glycerol, and 25 mM oxalate to a 
cryoprotectant solution consisting of 11.5% (w/v) PEG 8000, 90 mM 
BisTris (pH 6.0), 300 mM TMACl, 20% (v/v) glycerol, and 25 mM 
oxalate and flash cooled in liquid nitrogen. 
ΔBCΔBCCP RePC with 3-bromopyruvate or 3-hydroxypyruvate  
Ligand soaking was necessary to obtain the structures of 
ΔBCΔBCCP RePC with 3-bromopyruvate or 3-hydroxypyruvate. The 
protein solution consisting of 12.2 mg/mL ΔBCΔBCCP RePC, was mixed 
at a 1:1 ratio with the precipitant solution comprised of 11.3% (w/v) 
PEG 8000, 99 mM BisTris (pH 6.0), and 346 mM TMACl. The 
crystallization drop was seeded and covered with paraffin oil as 
described above. Apo crystals of ΔBCΔBCCP RePC were transferred 
and soaked in a mother liquor solution containing 10% (w/v) PEG 
8000, 80 mM BisTris (pH 6.0), 200 mM TMACl, and 80 mM 3-
bromopyruvate for 16 hours at room temperature. Similarly, apo 
crystals of ΔBCΔBCCP RePC with 3-hydroxypyruvate were transferred 
and soaked in an identical mother liquor solution for 24 hours with 130 
mM 3-hydroxypyruvate in place of 3-bromopyruvate. Crystals were 
then serially transferred in 5% (v/v) glycerol increments from the 
synthetic mother liquor solution to a cryoprotectant solution consisting 
of 11% (w/v) PEG 8000, 90 mM BisTris (pH 6.0), 200 mM TMACl, 80 
mM 3-bromopyruvate or 130 mM 3-hydroxypyruvate, and 20% (v/v) 
glycerol and flash cooled in liquid nitrogen. 
Data Collection, Structure Determination, and 
Refinement 
X-ray diffraction data were collected at the Advanced Photon 
Source (APS, Argonne, IL), beamline LS-CAT (Life Sciences 
Collaborative Access Team) 21-ID-G and 21-ID-F on Rayonix 
MarMosaic 300 CCD and 225 CCD detectors, respectively. The 
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wavelength for all structures was tuned to 0.979 Å and the diffraction 
images were processed with the HKL2000 suite [8]. The structures 
were solved by molecular replacement using the structure of 
ΔBCΔBCCP RePC (pdb i.d. 4JX4) as the search model with the program 
Phaser [9]. Following molecular replacement, 
translation/liberation/screw (TLS) refinements were performed using 
REFMAC [10]. Each monomer was treated as a rigid TLS group. All four 
monomers in the asymmetric unit were restrained using 
noncrystallographic symmetry for all models during the entire 
refinement process. The models were extended by several rounds of 
manual model building with COOT [11] and successive refinements 
with REFMAC. Water molecules were added to the models in COOT 
with subsequent manual verification. Data collection and processing 
statistics are summarized in Table 1. The atomic coordinates for 
ΔBCΔBCCP RePC with oxalate, ΔBCΔBCCP RePC with 3-
hydroxypyruvate and ΔBCΔBCCP RePC with 3-bromopyruvate have 
been deposited in the Protein Data Bank as entry 4MFD, 4MFE and 
4MIM, respectively. 
 
 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemical and Biophysical Research Communications, Vol. 441, No. 2 (November 2013): pg. 377-382. DOI. This article is 
© Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not 
grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Elsevier. 
7 
 
Results and Discussion 
Structure of the RePC CT domain with an intermediate 
analogue 
The carboxyl transfer reaction in the CT domain of PC is 
proposed to proceed through a stabilized enolpyruvate intermediate 
[2]. In the CT active site, carboxybiotin decarboxylates to release CO2. 
The resulting biotin enolate abstracts a proton from a nearby 
conserved threonine (Thr882 in RePC), which, in a concerted step, 
abstracts a proton from pyruvate to form the enolpyruvate 
intermediate. The enolpyruvate then attacks the liberated CO2 to form 
oxaloacetate [2]. The enolpyruvate is typically depicted as being 
stabilized through bidentate coordination to the Lewis acid metal at the 
center of the active site and mutations to residues coordinating this 
metal ion lead to a complete loss of enzymatic activity in PC [12]. 
However, to date, none of the crystal structures of PC co-crystallized 
with pyruvate show the substrate chelating the divalent active site 
metal through a bidentate interaction [3,6,13,14]. Instead, pyruvate is 
always oriented with just the carbonyl oxygen oriented toward the 
metal center and, furthermore, a water molecule is often observed to 
be bridging this interaction. 
Oxalate is the most potent inhibitor reported for PC. It is non-
competitive with respect to pyruvate with a reported Ki value of 70 μM 
[15], 50–130 μM [16], and 12 μM [17] for PC enzymes from yeast, rat 
liver, and chicken liver, respectively. Oxalate is competitive with 
respect to oxaloacetate and has a dissociation constant of 8.9 μM for 
the metal center of chicken liver PC [18]. At neutrality, the two 
carboxylates of oxalate are deprotonated (pKa1= 1.19; pKa2=4.22) 
[19]. In this ionization state, oxalate is a strong chelator of metal ions 
and shares structural and chemical properties with the enolpyruvate 
intermediate. Typically, enzymes that catalyze reactions proceeding 
through an enolpyruvate intermediate, such as pyruvate kinase and 
phosphoenolpyruvate caboxykinase, are abserved to bind oxalate as a 
bidentate ligand in the crystal structures [20–22]. 
A truncated construct of RePC was generated that lacked both 
the BC and BCCP domains and included only the allosteric and CT 
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domains of the enzyme (ΔBCΔBCCP RePC; [5]). Using isothermal 
titration calorimetry (ITC), the KD values for pyruvate and oxalate with 
ΔBCΔBCCP RePC were determined to be ~ 2 mM and 0.13 mM, 
respectively. These data indicate that oxalate binds the active site with 
a 15-fold greater affinity than the bona fide substrate, pyruvate. To 
gain further insights into the catalytic mechanism in the CT domain of 
PC, this construct was co-crystallized with oxalate in order to probe 
the binding orientation of an enolpyruvate intermediate analogue in 
the active site of the CT domain. 
As previously reported, ΔBCΔBCCP RePC crystallizes in the 
P212121 space group and the asymmetric unit is composed of four 
monomers in a dimer of dimers arrangement [5]. For all structures 
reported here, all monomers within each asymmetric unit are near 
identical to one another with the highest r.m.s. deviation for all atoms 
being 0.3 Å. The CT domain architecture consists of a canonical α8β8 
TIM barrel fold with a large C-terminal funnel, comprised of nine α-
helices, that leads into the active site at the mouth of the barrel. The 
active site is centered on the structurally conserved Lewis acid metal, 
which is either Mn2+ or Zn2+ [5]. 
Surprisingly, oxalate does not directly interact with the active 
site metal ion: the distance between the metal ion and oxalate is 4.5 
Å, with a bridging water molecule located 2.3 Å away from the metal 
(Figure 2A). Instead, it is positioned in the active site similarly to the 
substrates pyruvate (green; pdb i.d. 4JX5) and oxamate (yellow; pdb 
i.d. 4LOC) (Figure 2B). The planes of the carboxyl moieties for oxalate 
are staggered such that one carboxyl moiety forms a salt bridge with 
the guanidinium side-chain of Arg621 and the other maintains 
hydrogen bond interactions with Arg548 (3.1 Å) and Gln552 (3.3 Å), 
two residues that are essential for RePC catalysis [4]. Pyruvate and 
oxamate also interact with Arg621, Arg548 and Gln552, but they 
adopt a planar conformation in the active site of RePC ([5]; pdb i.d. 
4LOC). Because the planes of the oxalate carboxyl moieties are 
staggered, the carboxyl moiety closest to the metal center is 
positioned near to Thr882, the residue responsible for transferring a 
proton to the enolpyruvate intermediate in the oxaloacetate 
decarboxylation reaction. Additionally, the binding of oxalate appears 
to be specific, since it promotes a substrate-induced closure of the 
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active site through an interaction between the hydroxyl moiety of 
Tyr628 and the side chain of Asp590 [5]. 
 
Figure 2 A. Stereo view of representative electron density for the active site of 
ΔBCΔBCCP RePC co-crystallized with oxalate. The 2Fo-Fc electron density map is 
contoured at 1.0 σ and is represented as a grey mesh. The Fo-Fc omit density map is 
contoured at 3.0 σ and is represented as a green mesh. B. Structural overlay of 
ΔBCΔBCCP RePC with oxalate (cyan; monomer A) against the structures of ΔBCΔBCCP 
RePC with pyruvate (green; pdb i.d. 4JX5 - monomer A) and oxamate (yellow; pdb i.d. 
4LOC - monomer A). The rms deviation of the structure with oxalate against the 
structures with pyruvate and oxamate is 0.17 and 0.20 Å, respectively. 
The structure of ΔBCΔBCCP RePC with oxalate bound in the 
active site further clarifies the chemical mechanism in the CT domain 
of PC. Despite being an excellent metal chelator, oxalate does not form 
a bidentate interaction with the metal ion located at the center of the 
active site. This strongly suggests that the enolpyruvate intermediate 
formed during catalysis is not primarily stabilized through an 
interaction with the metal center. Instead, the developing negative 
charge in the enolpyruvate intermediate is stabilized through a salt 
bridge interaction with the guanidinium of Arg621 and interactions 
with Arg548, Gln552, and the metal. Mutating Arg548 and Gln552 in 
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RePC results in the complete loss of pyruvate carboxylation activity, 
further supporting a role for these amino acids in catalysis [4]. 
Notably, the glutamine/arginine pair (Arg548/Gln552) is conserved in 
the broader DRE-TIM metalloenzyme family that catalyzes carbon-
carbon bond cleavage on substrates that proceed through stabilization 
of an enolate intermediate [23]. As opposed to a bidentate interaction 
with the metal ion, the binding orientation adopted by pyruvate and 
oxalate permits free rotation about the C1–C2 bond to allow C3 to be 
properly positioned for proton transfer between C3 and the hydroxyl 
moiety of Thr882 and to orient the carbanion at C3 to attack the 
liberated CO2 from biotin. Interestingly, the only available structures of 
a homologous enzyme with bound products and substrates are from 
the 5S subunit of transcarboxylase, which also revealed that the 
substrates and products do not directly interact with the active site 
metal ion [24]. 
Structures of the CT domain from RePC with product 
analogues 
To date, attempts at capturing structures of oxaloacetate, the 
reaction product, in the active site of PC have been unsuccessful [6]. 
Both co-crystallization and soaking attempts with oxaloacetate have 
resulted in electron density corresponding to pyruvate in the active 
site ([6]). Capturing structures of oxaloacetate in the active site is 
complicated by the ability of the CT domain to catalyze the 
decarboxylation of oxaloacetate [5]. In order to gain insights into how 
oxaloacetate is positioned in the active site of PC, apo crystals of 
ΔBCΔBCCP RePC were soaked with 3-hydroxypyruvate and 3-
bromopyruvate, structural mimics of oxaloacetate and inhibitors of the 
carboxyl transfer reaction. 
3-hydroxypyruvate, which is a non-competitive inhibitor with 
respect to MgATP (Ki = 5.5 mM), HCO3− (Ki = 7.1 mM), and pyruvate 
(Ki = 5.4 mM) for the pyruvate carboxylation reaction from 
Thiobacillus novellus PC [25,26], binds in the active site of ΔBCΔBCCP 
RePC in a similar orientation to pyruvate. Like pyruvate, the carboxyl 
moiety of 3-hydroxypyruvate forms a salt bridge interaction with the 
guanidinium moiety of Arg621, while the C2 carbonyl oxygen is within 
hydrogen bonding distance to the side chains of Arg548 and Gln552 
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(Figure 3A). Interestingly, the hydroxyl moiety at C3 of 3-
hydroxypyruvate is positioned in close proximity to the side chain of 
Thr882. The position occupied by the hydroxyl moiety is likely to 
represent the position at which enolpyruvate is carboxylated during 
the reaction. Like pyruvate, oxamate, and oxalate [5,6]; pdb i.d. 
4LOC), 3-hydroxypyruvate is not a bidentate ligand and the binding of 
3-hydroxpyruvate promotes the closed conformation of the active site. 
 
Figure 3 Representative omit maps for (A) 3-hydroxypyruvate (3PY; purple) and 
(B) 3-bromopyruvate (BPV; grey) in the active site of ΔBCΔBCCP RePC. The electron 
density maps are contoured at 3.0 σ. 
Halogenating the C3 position of pyruvate results in effective, 
specific inhibitors of PC (reviewed in [27]). For instance, 
fluoropyruvate is a non-competitive inhibitor with respect to pyruvate 
(Ki = 0.17 mM) for the pyruvate carboxylation reaction [17], with 
pulse NMR data suggesting that it prevents pyruvate coordination in 
the active site [18]. Further, 10 mM fluoropyruvate and chloropyruvate 
inhibit gluconeogenesis by 85% and >95%, respectively, in the rat 
liver by modulating PC activity [28]. Given that halogenated 
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derivatives of pyruvate are potent inhibitors of PC, we determined the 
structure of ΔBCΔBCCP RePC with 3-bromopyruvate. 
3-bromopyruvate binds in the active site of ΔBCΔBCCP RePC in 
a similar manner to 3-hydroxypyruvate (Figure 3B). The carboxyl 
moiety of 3-bromopyruvate forms a salt bridge interaction with the 
guanidinium moiety of Arg621, and the bromine atom is positioned 
towards the side-chain of Thr882, much like the C3 hydroxyl moiety of 
3-hydroxypyruvate. However, a weaker binding orientation for 3-
brompyruvate, modeled at 0.2 occupancy, results in the bromine atom 
being positioned 2.3 Å away from the active site metal. Normally, the 
active site metal is octahedrally coordinated by the side chains of 
Asp549, His747, His749, carbamylated Lys718 and a water molecule. 
In this second binding mode, 3-bromopyruvate displaces the water 
molecule and directly interacts with the metal center. This interaction 
may explain the enhanced potency of halogenated pyruvate 
derivatives for PC. 
3-bromopyruvate has been described as an anti-cancer agent 
with a wide range of possible targets required for energy metabolism 
in tumor cells [29]. Most recently, 3-bromopyruvate has also been 
described as a novel antifungal agent against human pathogens such 
as Cryptococcus neoformans [30]. While it is recognized that 3-
bromopyruvate targets multiple metabolic pathways, to our knowledge 
PC has not been recognized as a specific target for 3-bromopyruvate. 
Based on the current findings, PC inhibition should be considered when 
interpreting the mechanism of cellular inhibition for 3-bromopyruvate 
and other halogenated derivatives of pyruvate. 
In summary, we report three X-ray crystal structures of the 
RePC CT domain with the bound inhibitors oxalate, 3-hydroxypyruvate, 
and 3-bromopyruvate. Oxalate, which may be considered an analogue 
of the enolpyruvate reaction intermediate, does not form a bidentate 
interaction with the active site metal, contrary to what has long been 
assumed for intermediate stabilization in PC. Instead, the enolpyruvate 
intermediate is stabilized through a positively charged pocket that 
includes interactions with Arg621, Arg548, Gln552 in addition to the 
active site metal. Further, 3-hydroxypyruvate and 3-bromopyruvate, 
mimcs of the reaction product oxaloacetate, are positioned in the 
active site such that the C3 bromo/hydroxyl moiety faces the side 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemical and Biophysical Research Communications, Vol. 441, No. 2 (November 2013): pg. 377-382. DOI. This article is 
© Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not 
grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Elsevier. 
13 
 
chain of Thr882. This positioning strongly suggests that the substrate 
maintains its orientation in the active site as catalysis proceeds. Two 
binding modes are suggested in the structure of 3-bromopyruvate. The 
altered positioning relative to the active site metal may explain the 
increased inhibition potency of halogenated pyruvate derivatives for PC 
and demonstrates that PC may factor into the anti-tumor and anti-
fungal mechanism of 3-bromopyruvate. 
Highlights 
 Structures of pyruvate carboxylase were determined in the presence of 
three ligands 
 Unexpectedly, none of the ligands directly coordinate the active site 
metal ion 
 Structures suggest that substrate orientation remains fixed throughout 
catalysis 
 3-Bromopyruvate binds in the active site of pyruvate carboxylase 
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